| Literature DB >> 29445362 |
Fehmida Bibi1, Gary A Strobel2, Muhammad I Naseer3, Muhammad Yasir1, Ahmed A Khalaf Al-Ghamdi4, Esam I Azhar1,4.
Abstract
Halophytes are associated with the intertidal forest ecosystem of Saudi Arabia and seemingly have an immense potential for yielding useful and important natural products. In this study we have aimed to isolate and characterize the endophytic and rhizospheric bacterial communities from the halophyte, Salsola imbricata, In addition these bacterial strains were identified and selected strains were further studied for bioactive secondary metabolites. At least 168 rhizspheric and endophytic bacteria were isolated and of these 22 were active antagonists against the oomycetous fungal plant pathogens, Phytophthora capsici and Pythium ultimum. Active cultures were mainly identified with molecular techniques (16S r DNA) and this revealed 95.7-100% sequence similarities with relevant type strains. These microorgansims were grouped into four major classes: Actinobacteria, Firmicutes, β-Proteobacteria, and γ-Proteobacteria. Production of fungal cell wall lytic enzymes was detected mostly in members of Actinobacteria and Firmicutes. PCR screening for type I polyketide synthases (PKS-I), type II polyketide synthases (PKS-II) and nonribosomal peptide synthetases (NRPS) revealed 13 of the 22 strains (59%) were positive for at least one of these important biosynthetic genes that are known to be involved in the synthesis of important antibiotics. Four bacterial strains of Actinobacteria with potential antagonistic activity including two rhizobacteria, EA52 (Nocardiopsis sp.), EA58 (Pseudonocardia sp.) and two endophytic bacteria Streptomyces sp. (EA65) and Streptomyces sp. (EA67) were selected for secondary metabolite analyses using LC-MS. As a result, the presence of different bioactive compounds in the culture extracts was detected some of which are already reported for their diverse biological activities including antibiotics such as Sulfamethoxypyridazine, Sulfamerazine, and Dimetridazole. In conclusion, this study provides an insight into antagonistic bacterial population especially the Actinobacteria from S. imbricata, producing antifungal metabolites of medical significance and characterized taxonomically in future.Entities:
Keywords: 16S rRNA gene sequence; LC/MS analyses; antifungal activity; enzyme production; halophyte
Year: 2018 PMID: 29445362 PMCID: PMC5797760 DOI: 10.3389/fmicb.2018.00065
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Distribution of rhizopheric and endophytic antagonistic bacteria isolated from halophyte.
| Rhizopheric (Soil) | 85 | 8 | 4.7 | |
| Endophytes (Roots) | 48 | 9 | 5.4 | |
| Endophytes (Leaves) | 35 | 5 | 2.9 | |
| 168 | 22 | 13% |
Isolation source of rhizopheric and endophytic bacteria.
Total number of rhizopheric and endophytic bacteria isolated from soil, roots and leaves of halophyte.
Total number of antagonistic rhizopheric and endophytic bacteria.
Percentage of antagonistic rhizopheric and endophytic bacteria.
Dominant phylum in all rhizopheric and endophytic antagonistic bacteria.
Taxonomic identification, antifungal acitivity, and enzymes production of rhizo and endophytic bacteria from halophyte.
| EA51 | 99.8 | W | W | − | − | − | ++++ | − | ++++ | − | + | − | − | ||
| EA52 | 99.7 | ++++ | +++ | + | ++ | − | ++++ | − | − | +++ | + | − | + | ||
| EA53 | 98.9 | ++++ | ++++ | +++ | − | − | − | − | − | − | − | − | − | ||
| EA54 | 99.8 | + | + | + | − | − | − | − | − | − | − | + | − | ||
| EA55 | 100 | + | W | − | + | − | − | − | ++++ | − | − | + | − | ||
| EA56 | 98.9 | + | + | − | − | − | − | − | − | − | − | − | − | ||
| EA57 | 99.3 | + | W | − | + | − | ++++ | ++++ | − | − | + | − | − | ||
| EA58 | 100 | ++++ | ++++ | +++ | ++++ | + | − | − | − | − | − | + | − | ||
| EA59 | 99.9 | ++++ | +++ | + | − | − | ++++ | +++++ | ++++ | − | − | − | − | ||
| EA60 | 99.4 | +++ | ++ | + | +++ | ++ | ++++ | +++++ | − | − | − | − | − | ||
| EA61 | 99.4 | +++ | + | + | +++ | − | +++ | +++++ | − | − | + | − | + | ||
| EA62 | 98.8 | + | W | − | − | − | − | − | − | − | − | − | − | ||
| EA63 | 100 | + | ++ | − | − | − | +++ | W | − | − | + | − | + | ||
| EA64 | 99.3 | +++ | +++ | +++ | − | − | − | − | ++++ | − | + | − | + | ||
| EA65 | 97.3 | ++ | ++ | + | − | + | − | − | − | − | − | − | + | ||
| EA66 | 95.7 | ++ | + | + | +++ | +++ | − | − | ++++ | − | + | − | − | ||
| EA67 | 98.2 | ++ | + | ++ | +++ | + | +++ | − | − | − | − | − | + | ||
| EA68 | 100 | + | W | − | − | − | − | − | − | − | − | − | − | ||
| EA69 | 99.1 | + | + | − | − | − | − | +++++ | ++++ | − | − | − | − | ||
| EA70 | 100 | ++ | + | − | − | − | − | ++ | − | − | − | − | − | ||
| EA71 | 98.9 | +++ | + | + | − | +++ | − | − | − | − | − | − | − | ||
| EA72 | 99.3 | + | ++ | ++ | + | − | +++ | − | +++ | − | + | + | + | ||
Antagonistic activity of all bacteria isolated in this study. The activity was measured after 3–5 days incubation at 28°C by measuring the clear zone of mycelial growth inhibition: W, weak; –, Negative; +, 3 mm; ++, between 4 and 6 mm; +++, between 7 and 9 mm; ++++, between 10 and 12 mm.
Production of protease, amylase, lipase, and cellulase was determined by plate assay. Enzymatic activity was estimated as zone of halo formed around bacterial colonies: W, weak; −, Negative; +, 3 mm; ++, between 4 and 6 mm; +++, between 7 and 9 mm; ++++, between 10 and 12.
Figure 1Phylogenetic distribution of antagonistic bacteria isolated from S.imbricata on the basis of 16S rRNA gene sequences obtained from bacteria and closely related sequences of the type strains of other species. The phylogenetic relationships were inferred from the 16S rRNA gene sequences (1 kb) by using the neighbor-joining method from distances computed with the Jukes-Cantor algorithm. Bootstrap values (1,000 replicates) are shown next to the branches. GenBank accession numbers for each sequence are shown in parentheses. Bar, 0.01 accumulated changes per nucleotide. Isolates selected for bioactive metabolites identification are highlighted.
Tentative novel taxa based on partial 16S rRNA gene sequence analyses from this study.
| Rhizosphere (Soil) | 98.9 | Gram-negative | ||
| Rhizosphere (Soil) | 98.9 | Gram-positive | ||
| Endophytic (Root) | 98.8 | Gram-positive | ||
| Endophytic (Root) | 97.3 | Gram-positive | ||
| Endophytic (Root) | 95.7 | Gram-positive | ||
| Endophytic (Leaf) | 98.2 | Gram-positive | ||
| Endophytic (Leaf) | 98.9 | Gram-positive |
Secondary metabolites found in crude extract of selected four Actinobacteria strains.
| 1 | Thiabendazole | C10 H7 N3 S | 0.962 | 201.037 | 201.0366 | 44.89 | −2.4 | Negative | 36878 | 184023 |
| 2 | Sulfamethoxypyridazine | C11 H12 N4 O3 S | 1.125 | 279.0582 | 280.0655 | 75.22 | −9.01 | Negative | 44633 | 255086 |
| 3 | N-Nitrosodiethylamine | C4 H10 N2 O | 1.579 | 215.0641 | 102.0784 | 46.98 | 8.48 | Negative | 23538 | 232204 |
| 4 | Ibuprofen | C13 H18 O2 | 2.042 | 189.127 | 206.1303 | 92.03 | 2.07 | Positive | 62696 | 509785 |
| 5 | Laberalol | C19 H24 N2 O3 | 2.8 | 329.1839 | 328.1766 | 81.9 | 6.46 | Positive | 54189 | 463656 |
| 6 | Isoxsuprine | C18 H23 N O3 | 2.892 | 302.1733 | 301.1658 | 82.96 | 6.73 | Positive | 139154 | 2034111 |
| 7 | Oxibendazole | C12 H15 N3 O3 | 3.533 | 250.1187 | 249.1114 | 97.67 | −0.32 | Positive | 126155 | 961667 |
| 8 | Sulfamethoxypyridazine | C11 H12 N4 O3 S | 1.117 | 279.0575 | 280.0647 | 67.12 | −6.21 | Negative | 15321 | 77965 |
| 9 | Sulfadiazin | C10 H10 N4 O2 S | 2.683 | 249.0475 | 250.055 | 72.64 | −10.1 | Negative | 29954 | 210781 |
| 10 | Dimetridazole | C5 H7 N3 O2 | 4.045 | 159.0876 | 141.0527 | 70.14 | 8.14 | Positive | 111793 | 948315 |
| 11 | Sulfamethoxypyridazine | C11 H12 N4 O3 S | 1.126 | 279.0574 | 280.0649 | 80.47 | −6.78 | Negative | 47164 | 293920 |
| 12 | Sulfadiazin | C10 H10 N4 O2 S | 2.686 | 249.0474 | 250.0548 | 74.78 | −9.52 | Negative | 41010 | 344049 |
| 13 | Sulfacetamide | C8 H10 N2 O3 S | 1.793 | 215.0474 | 214.0401 | 72.66 | 5.06 | Positive | 68031 | 563882 |
| 14 | Dimetridazole | C5 H7 N3 O2 | 4.039 | 159.0881 | 141.0535 | 82.65 | 2.25 | Positive | 211556 | 1889105 |
| 15 | Salbuterol | C13 H21 N O3 | 15.786 | 239.1764 | 239.1532 | 47.28 | −4.28 | Positive | 1181230 | 8578877 |
| 16 | Moxidectin | C37 H53 N O8 | 16.671 | 662.3704 | 639.3739 | 49.37 | 4.97 | Positive | 95729 | 1314871 |
| 17 | Atenolol | C14 H22 N2 O3 | 17.318 | 267.1729 | 266.1657 | 77.62 | −10.11 | Positive | 907768 | 7927165 |
| 18 | Timolol | C13 H24 N4 O3 S | 21.415 | 317.1641 | 316.1571 | 73.26 | −0.54 | Positive | 67063 | 538273 |
| 19 | Benzydamine | C19 H23 N3 O | 21.419 | 310.1884 | 309.1797 | 21.59 | 14.35 | Positive | 89361 | 929352 |
| 20 | Acebutolol | C18 H28 N2 O4 | 21.711 | 336.2052 | 336.2045 | 59.81 | 1.09 | Positive | 88941 | 887397 |
| 21 | Bambuterol | C18 H29 N3 O5 | 21.714 | 367.2376 | 367.2098 | 51.49 | 2.53 | Positive | 58314 | 570222 |
| 22 | Sulfamethoxypyridazine | C11 H12 N4 O3 S | 1.122 | 279.0576 | 280.0651 | 80.42 | −7.33 | Negative | 30594 | 156782 |
| 23 | Sulfadiazin | C10 H10 N4 O2 S | 2.682 | 249.0471 | 250.0545 | 78.19 | −8.26 | Negative | 44098 | 367641 |
| 24 | Sulfanilamide | C6 H8 N2 O2 S | 0.748 | 173.0376 | 172.0307 | 91.12 | −0.47 | Positive | 95732 | 1075748 |
| 25 | Sulfadiazin | C10 H10 N4 O2 S | 1.223 | 251.058 | 250.0508 | 65.17 | 6.67 | Positive | 99002 | 476334 |
| 26 | Sulfacetamide | C8 H10 N2 O3 S | 1.8 | 215.0475 | 214.0404 | 90.98 | 3.98 | Positive | 142535 | 1446212 |
| 27 | Benzamide | C7 H7 N O | 2.72 | 103.0426 | 121.0525 | 37.43 | 1.82 | Positive | 641812 | 5370210 |
| 28 | Sulfamerazine | C11 H12 N4 O2 S | 2.991 | 265.0734 | 264.0662 | 65 | 7.1 | Positive | 59659 | 389438 |
| 29 | Dimetridazole | C5 H7 N3 O2 | 4.059 | 159.0879 | 141.0531 | 75.55 | 5.01 | Positive | 149866 | 1286924 |
| 30 | Metronidazole–oh | C6 H9 N3 O4 | 4.06 | 188.0669 | 187.0597 | 95.68 | −1.89 | Positive | 1776794 | 17824964 |
| 31 | Carazolol | C18 H22 N2 O2 | 20.924 | 303.1474 | 298.1688 | 42.24 | −2.22 | Positive | 81193 | 668836 |
Figure 2Spectra of LC/MS analysis showing detection of various bioactive metabolites. Nocardiopsis sp. (EA52) (A) negative mode LC/MS analysis (B) positive mode LC/MS analysis (C) negative mode LC/MS analysis of Pseudonocardia sp. (EA58) (D) positive mode LC/MS analysis (E) negative mode LC/MS analysis of Streptomyces sp. (EA65) (F) positive mode LC/MS analysis (G) negative mode LC/MS analysis of Streptomyces sp. (EA67) (H) positive mode LC/MS analysis.